Case File №
#VI-2026-0499
Shaanxi Dideu Medichem
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 6 | 4.9 | 0.0 | 7.4 | 3 Jun 2025 |
| 1-Testosterone Cypionate (DHB) Raw | X N/A | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 1 | 4.0 | 3.9 | 3.9 | 21 May 2025 |
| Adipotide | X N/A | 1 | 5.0 | 5.0 | 5.0 | 7 May 2025 |
| AICAR | X N/A | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 |
| Andarine (S-4) Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 14 Jan 2025 |
| Benzaldehyde CAS 100-52-7 | X N/A | 1 | 4.7 | 4.7 | 4.7 | 25 Apr 2025 |
| BMK glycidic acid (free acid) CAS 25547-51-7 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 27 Feb 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 3.6 | 3.6 | 14 Jan 2025 |
| Cartalax | X N/A | 1 | 4.0 | 3.2 | 3.2 | 25 Apr 2025 |
| Cerebrolysin | X N/A | 1 | 5.8 | 5.8 | 5.8 | 25 Apr 2025 |
| Clenbuterol | X N/A | 1 | 4.0 | 2.8 | 2.8 | 7 May 2025 |
| Crystagen | X N/A | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 |
| Dianabol Oil | X N/A | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 |
| DNP | X N/A | 1 | 4.0 | 3.8 | 3.8 | 24 Apr 2025 |
| Enclomiphene | X N/A | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 |
| Epithalon | X N/A | 1 | 4.0 | 4.0 | 4.0 | 3 Jul 2025 |
| EPO | X N/A | 1 | 4.0 | 3.3 | 3.3 | 2 Jul 2025 |
| FOXO4 | X N/A | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 |
| GHRP-2 Acetate | X N/A | 1 | 5.7 | 5.7 | 5.7 | 14 Jan 2025 |
| IGF-1 LR3 | X N/A | 1 | 5.2 | 5.2 | 5.2 | 16 Mar 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 24 Apr 2025 |
| Methylene Blue | X N/A | 1 | 5.0 | 5.0 | 5.0 | 3 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 |
| NandroMix 300 | X N/A | 1 | 7.8 | 7.8 | 7.8 | 16 Mar 2025 |
| Orforglipron | X N/A | 1 | 7.1 | 7.1 | 7.1 | 6 May 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 9 Jun 2025 |
| Pancragen | X N/A | 1 | 6.5 | 6.5 | 6.5 | 17 Dec 2024 |
| Pinealon | X N/A | 1 | 4.6 | 4.6 | 4.6 | 21 May 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 2.7 | 2.7 | 3 Jul 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 4.1 | 4.1 | 4.1 | 8 Jul 2025 |
| Sildenafil Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Jun 2025 |
| SR9009 | X N/A | 1 | 4.0 | 4.0 | 4.0 | 20 Jun 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 1 | 4.0 | 3.2 | 3.2 | 28 Mar 2025 |
| Test Enanthate | X N/A | 1 | 4.0 | 3.7 | 3.7 | 2 Jul 2025 |
| Trenbolone Enanthate Raw | X N/A | 1 | 6.8 | 6.8 | 6.8 | 9 Jun 2025 |
| Vilon | X N/A | 1 | 4.2 | 4.2 | 4.2 | 9 Jun 2025 |
| VIP | X N/A | 1 | 7.3 | 7.3 | 7.3 | 2 Jul 2025 |
Exhibit II
Evidence Log
43 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Test Enanthate | 4.0 C | 100mg/ml | 107.8mg/ml | +7.8% | 96.37% | d6fw5w | Lab D | Public |
| 24 May 2026 | DNP | 4.0 C | 50mg | 53.4mg | +6.8% | 97.87% | hdo16w | Lab G | Community |
| 24 May 2026 | Cartalax | 5.2 B | 50mg | 55.8mg | +11.6% | 99.85% | b8eazi | Lab F | Public |
| 23 May 2026 | Crystagen | 5.0 B | 5mg | 5.0mg | -0.2% | 96.54% | icbpox | Lab A | Community |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.7 C | 10mg | 10.4mg | +4.0% | 95.55% | 5562pe | Lab A | Public |
| 23 May 2026 | Epithalon | 4.0 C | 5mg | 5.0mg | +0.0% | 96.37% | 7s6685 | Lab D | Public |
| 21 May 2026 | Methylene Blue | 4.8 C | 100mg | 93.1mg | -6.9% | 95.75% | c5u2in | Lab G | Public |
| 21 May 2026 | BMK glycidic acid (free acid) CAS 25547-51-7 | 7.2 A | 1g | 1.2g | +17.6% | 95.09% | 2dfuz7 | Lab C | Public |
| 21 May 2026 | Sildenafil Raw | 6.0 A | 500g | 509.5g | +1.9% | 97.84% | eqpa6f | Lab E | Community |
| 20 May 2026 | IGF-1 LR3 | 5.7 B | 30mg | 32.4mg | +8.1% | 98.91% | 2b5hcy | Lab B | Public |
| 20 May 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 4.0 C | 100mg/ml | 120.9mg/ml | +20.9% | 96.37% | iria0x | Lab E | Public |
| 20 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 4.0 C | 5mg | 5.9mg | +18.5% | 99.29% | w0ih9m | Lab E | Public |
| 19 May 2026 | NandroMix 300 | 10.0 A | 250mg/ml | 282.4mg/ml | +13.0% | 98.71% | ffbf49 | Lab D | Public |
| 19 May 2026 | VIP | 7.3 A | 15mg | 15.2mg | +1.2% | 99.28% | gzhc5j | Lab F | Community |
| 17 May 2026 | Adipotide | 4.0 C | 20mg | 20.5mg | +2.6% | 97.47% | 4zvuhk | Lab C | Public |
| 17 May 2026 | Clenbuterol | 6.3 A | 100mg | 116.5mg | +16.5% | 98.36% | 7mgjqq | Lab F | Public |
| 17 May 2026 | Trenbolone Enanthate Raw | 6.4 A | 100g | 115.1g | +15.1% | 96.28% | szhwxx | Lab G | Public |
| 29 Jan 2026 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Red Crimp / Clear Cap | Lab E | — | — |
| 29 Jan 2026 | Tamoxifen (Nolvadex) | 5.2 B | 100mg | 88.4mg | -11.6% | 95.70% | ubd938 | Lab F | Public |
| 29 Jan 2026 | Vilon | 4.0 C | 30mg | 27.0mg | -9.8% | 97.07% | mlz9le | Lab G | Public |
| 19 Jan 2026 | Enclomiphene | 6.8 A | 20mg | 23.1mg | +15.5% | 95.66% | l9ig9j | Lab F | Community |
| 7 Jan 2026 | Orforglipron | 7.4 A | 25mg | 28.3mg | +13.3% | 96.45% | p0aabq | Lab C | Public |
| 7 Jan 2026 | Pinealon | 4.8 C | 50mg | 46.6mg | -6.9% | 96.57% | 1j3ddq | Lab C | Public |
| 6 Jan 2026 | AICAR | 6.8 A | 2mg | 2.1mg | +4.1% | 98.67% | 7jm0hp | Lab G | Public |
| 6 Jan 2026 | Benzaldehyde CAS 100-52-7 | 5.5 B | 100g | 102.5g | +2.5% | 99.19% | ez8sch | Lab C | Community |
| 6 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.1 C | 30mg | 27.4mg | -8.8% | 96.00% | 104oab | Lab B | Public |
| 6 Jan 2026 | PTD-DBM | 4.1 C | 10mg | 10.0mg | -0.2% | 97.10% | c9hxxf | Lab D | Community |
| 29 Dec 2025 | Andarine (S-4) Raw | 4.0 C | 100g | 106.6g | +6.6% | 98.08% | 93gtg0 | Lab A | Public |
| 13 Dec 2025 | Retatrutide | 7.2 A | 20mg | 21.2mg | +6.0% | 99.70% | (no batch ID) | Lab G | Public |
| 12 Dec 2025 | Pancragen | 6.1 A | 10mg | 9.9mg | -1.5% | 96.89% | 2q6enp | Lab A | Public |
| 23 Nov 2025 | 1-Testosterone Cypionate (DHB) Raw | 4.4 C | 10g | 9.8g | -1.8% | 99.73% | mmo3q3 | Lab B | Public |
| 23 Nov 2025 | SR9009 | 5.1 B | 100mg | 109.1mg | +9.1% | 95.48% | lwb5r8 | Lab C | Public |
| 14 Nov 2025 | GHRP-2 Acetate | 7.0 A | 30mg | 29.4mg | -2.1% | 95.26% | 56ibnx | Lab D | Public |
| 5 Nov 2025 | Cerebrolysin | 5.9 B | 20mg | 17.1mg | -14.4% | 97.75% | qtcslf | Lab F | Public |
| 5 Nov 2025 | EPO | 4.0 C | 30mg | 27.9mg | -6.9% | 98.19% | laxtbx | Lab E | Public |
| 4 Nov 2025 | Retatrutide | 7.4 A | 5mg | 4.92mg | -1.6% | 99.66% | (no batch ID) | Lab E | Public |
| 4 Nov 2025 | FOXO4 | 4.4 C | 20mg | 22.3mg | +11.7% | 98.78% | n0yh7c | Lab F | Public |
| 29 Oct 2025 | Retatrutide | 4.3 D | 5mg | 6.06mg | +21.2% | 99.61% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | Dianabol Oil | 5.6 B | 100mg/ml | 98.4mg/ml | -1.6% | 97.29% | ogqcwy | Lab F | Public |
| 9 Oct 2025 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 4.0 C | 500g | 457.2g | -8.6% | 97.15% | omqbs5 | Lab B | Community |
| 9 Oct 2025 | Ostarine (MK-2866) | 4.1 C | 10mg | 10.2mg | +1.6% | 98.19% | h2mywo | Lab E | Public |
| 3 Oct 2025 | Masteron P (Drostanolone P) | 4.9 C | 250mg/ml | 305.1mg/ml | +22.0% | 99.95% | 8bldh1 | Lab A | Public |
| 3 Jun 2025 | Retatrutide | 6.4 B | 20mg | 22.1mg | +10.5% | 99.98% | (no batch ID) | Lab E | Public |